13th Annual NATA Symposium
Scientific Program
Thursday, April 12, 2012
MORNING
8:45-9:00 Welcome Addresses
Dafydd Thomas, Swansea, Wales, UK
Pär I. Johansson, Copenhagen, Denmark
BLOOD SAFETY: THE RISK OF BLOOD ADMINISTRATION
Dafydd Thomas, Swansea, Wales, UK
Manuel Muñoz, Málaga, Spain
9:00-9:20 The Effects of Transfusion on Innate Immunity
Walter G. Land, Munich, Germany
9:20-9:40 Transfusion Errors: How They Occur and Novel Systems to Improve the Safety of Blood Administration
Mike Murphy, Oxford, UK
9:40-10:00 The German Registry for Transfusion Errors
Thomas Frietsch, Marburg, Germany
10:00-10:30 Questions and Answers
10:30-11:00 Break
PLATELET TRANSFUSIONS: EFFECTIVE AND SAFE?
Philippe Van der Linden, Brussels, Belgium
Pär I. Johansson, Copenhagen, Denmark
11:00-11:20 Platelet Products: What Are We Transfusing?
Rainer Moog, Bernau, Germany
11:20-11:40 Platelet Transfusion: Indications and Efficacy
Mike Murphy, Oxford, UK
11:40-12:00 Emerging Issues in Platelet Therapy
Lawrence Tim Goodnough, Stanford, CA, USA
12:00-12:30 Questions and Answers
WORKSHOP: MANAGEMENT OF PREOPERATIVE ANEMIA
Elvira Bisbe, Barcelona, Spain
Jeffrey L. Carson, New Brunswick, NJ, USA
11:00-12:30 (Maximum 25 participants)
WORKSHOP: INTERACTIVE CASE SCENARIO: OBSTETRIC HEMORRHAGE
Alexander Krafft, Zurich, Switzerland
Jakob Stensballe, Copenhagen, Denmark
11:00-12:30 (Maximum 25 participants)
12:30-14:30 Lunch Break, Satellite Symposia
LUNCHTIME SATELLITE SYMPOSIUM: MANAGEMENT OF PERIOPERATIVE BLEEDING
Supported by an educational grant from CSL Behring
Oliver Habler, Frankfurt, Germany
Jørgen Ingerslev, Aarhus, Denmark
12:45-13:05 POC Monitoring for Massive Bleeding – A Paradigm Shift?
Herbert Schöchl, Vienna, Austria
13:05-13:25 Treatment Algorithm According to POC Test Results – Is There Evidence?
Klaus Görlinger, Essen, Germany
13:25-13:45 ”Just in Time” – A Coagulation Concept in Critical Bleeding Became Reality
Thomas Volk, Homburg, Germany
13:45-14:15 Discussion
Thursday, April 12, 2012
AFTERNOON
FLUID THERAPY IN THE OPERATING ROOM AND IN THE INTENSIVE CARE UNIT
Hans Gombotz, Linz, Austria
Anders Perner, Copenhagen, Denmark
14:30-14:50 The Importance of Plasma Viscosity
Amy G. Tsai, San Diego, CA, USA
14:50-15:10 Balanced Solutions: A Balanced View
Philippe Van der Linden, Brussels, Belgium
15:10-15:30 Albumin: Back to the Future
Anders Perner, Copenhagen, Denmark
15:30-16:00 Questions and Answers
WORKSHOP: POINT-OF-CARE COAGULATION MONITORING: TEG, ROTEM
Pär I. Johansson, Copenhagen, Denmark
Klaus Görlinger, Essen, Germany
14:30-16:00 (Maximum 25 participants)
WORKSHOP: BLOOD CONSERVATION STRATEGIES FOR HIGH-RISK SURGERY
Oliver Habler, Frankfurt, Germany
Manuel Muñoz, Málaga, Spain
14:30-16:00 (Maximum 25 participants)
16:00-16:30 Break
BEST POSTERS’ PRESENTATION
Jean-François Hardy, Montreal, QC, Canada
Lars Rasmussen, Copenhagen, Denmark
16:30-16:45 Efficacy, Safety and Cost-Benefit of “Double Unit” Red Blood Cell Concentrate by Apheresis: Comparison with Collection of 1 or 2 Units of Whole Blood
Ivo Beverina, Legnano, Italy
16:45-17:00 A UK National Comparative Audit of the Medical Use of Red Cells
John Grant-Casey, Oxford, UK
17:00-17:15 Intraoperative Cell Salvage in Obstetrics – The Present and the Future
Catherine Ralph, Cornwall, UK
17:15-17:30 No Impact of a Massive Transfusion Protocol on Coagulopathy and Mortality at a Level 1 Trauma Center – Why?
Caroline Bourassa-Fulop, Montreal, QC, Canada
17:45-18:30 NATA General Assembly
Friday, April 13, 2012
MORNING
BREAKING NEWS
Dafydd Thomas, Swansea, Wales, UK
Astrid Nørgaard, Copenhagen, Denmark
9:00-9:20 Age of Blood in Neonates – The ARIPI Trial
Dean A. Fergusson, Ottawa, ON, Canada
9:20-9:40 Hydroxyethyl Starch Versus Balanced Crystalloid in Patients With Severe Sepsis
Anders Pener, Copenhagen, Denmark
9:40-10:00 NATA European Benchmark Study
Philippe Van der Linden, Brussels, Belgium
10:00-10:30 Questions and Answers
10:30-11:00 Break
THE MANAGEMENT OF MASSIVE HEMORRHAGE IN OBSTETRICS
Pär I. Johansson, Copenhagen, Denmark
Jakob Stensballe, Copenhagen, Denmark
11:00-11:20 The Obstetrician’s Perspective
Alexander Krafft, Zurich, Switzerland
11:20-11:40 The Anesthesiologist’s Perspective
Jakob Stensballe, Copenhagen, Denmark
11:40-12:00 The Blood Banker’s Perspective
Lawrence Tim Goodnough, Stanford, CA, USA
12:00-12:30 Questions and Answers
WORKSHOP: MANAGEMENT OF PREOPERATIVE ANEMIA
Elvira Bisbe, Barcelona, Spain
Jeffrey L. Carson, New Brunswick, NJ, USA
11:00-12:30 (Maximum 25 participants)
WORKSHOP: BLOOD CONSERVATION STRATEGIES FOR HIGH-RISK SURGERY
Oliver Habler, Frankfurt, Germany
Manuel Muñoz, Málaga, Spain
11:00-12:30 (Maximum 25 participants)
12:30-14:30 Lunch Break
Friday, April 13, 2012
AFTERNOON
PERIOPERATIVE MANAGEMENT OF NEW ANTITHROMBOTIC AGENTS
Charles-Marc Samama, Paris, France
Sisse Ostrowski, Copenhagen, Denmark
14:30-14:50 New Oral Anticoagulants and Monitoring Their Effect
Philippe de Moerloose, Geneva, Switzerland
14:50-15:10 Risk and Management of Bleeding in Patients on New Oral Anticoagulants
Anne Godier, Paris, France
15:10-15:30 Risk and Management of Bleeding in Patients on New Antiplatelet Agents
Charles-Marc Samama, Paris, France
15:30-16:00 Questions and Answers
WORKSHOP: POINT-OF-CARE COAGULATION MONITORING: TEG, ROTEM
Pär I. Johansson, Copenhagen, Denmark
Klaus Görlinger, Essen, Germany
14:30-16:00 (Maximum 25 participants)
WORKSHOP: INTERACTIVE CASE SCENARIO: OBSTETRIC HEMORRHAGE
Alexander Krafft, Zurich, Switzerland
Jakob Stensballe, Copenhagen, Denmark
14:30-16:00 (Maximum 25 participants)
16:00-16:30 Break
RED BLOOD CELL TRANSFUSION IN 2012
Oliver Habler, Frankfurt, Germany
Jean-François Hardy, Montreal, QC, Canada
16:30-16:50 Transfusion Triggers: Where Do We Stand?
Jeffrey L. Carson, New Brunswick, NJ, USA
16:50-17:10 Perfusion vs. Oxygen Delivery in Transfusion with “Fresh” And “Old” Red Blood Cells: The Experimental Evidence
Amy G. Tsay, San Diego, CA, USA
17:10-17:30 Questions and Answers
17:30 Concluding Comments
Dafydd Thomas, Swansea, Wales, UK
